Free Trial

Nutex Health (NASDAQ:NUTX) Sets New 1-Year High Following Insider Buying Activity

Nutex Health logo with Medical background

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s share price reached a new 52-week high during mid-day trading on Tuesday following insider buying activity. The company traded as high as $137.32 and last traded at $129.67, with a volume of 212340 shares changing hands. The stock had previously closed at $132.03.

Specifically, CFO Jon Christian Bates acquired 1,000 shares of the business's stock in a transaction on Tuesday, April 8th. The shares were acquired at an average cost of $81.81 per share, with a total value of $81,810.00. Following the transaction, the chief financial officer now owns 4,888 shares in the company, valued at $399,887.28. The trade was a 25.72 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.

Analyst Ratings Changes

Separately, Maxim Group raised their target price on Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a research note on Tuesday, April 8th.

Get Our Latest Stock Report on NUTX

Nutex Health Stock Performance

The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. The company's 50 day moving average is $71.04 and its 200-day moving average is $46.10. The company has a market capitalization of $823.67 million, a P/E ratio of -15.87 and a beta of 0.27.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings results on Monday, March 31st. The company reported $11.12 EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $11.21. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The firm had revenue of $81.30 million for the quarter, compared to analysts' expectations of $81.13 million.

Institutional Investors Weigh In On Nutex Health

Institutional investors have recently modified their holdings of the stock. Drive Wealth Management LLC purchased a new stake in Nutex Health during the 4th quarter valued at about $1,122,000. Legato Capital Management LLC increased its position in shares of Nutex Health by 26.8% during the fourth quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock valued at $1,004,000 after acquiring an additional 6,697 shares in the last quarter. Baader Bank Aktiengesellschaft purchased a new position in Nutex Health in the 4th quarter worth approximately $206,000. American Century Companies Inc. acquired a new position in shares of Nutex Health in the 4th quarter valued at $1,362,000. Finally, Truist Financial Corp lifted its position in Nutex Health by 22.2% during the 4th quarter. Truist Financial Corp now owns 35,570 shares of the company's stock worth $1,127,000 after acquiring an additional 6,454 shares during the period. 5.32% of the stock is owned by hedge funds and other institutional investors.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

See Also

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines